[ad_1] Investors hoping to capture more upside from artificial intelligence could turn to a sector that’s underperformed this year, and maybe not immediately associated with AI: Health care. A handful of large tech names surged in the first half thanks to a mania for all things tied to artificial intelligence. Apple, for example, last week…
[ad_1] Bill Ackman Scott Mlyn | CNBC Bill Ackman said in 2021 that delaying Covid vaccinations for older Americans “seems like genocide.” Today, the influential hedge fund chief and investor is amplifying the debunked anti-vaccine views of Democratic presidential candidate Robert F. Kennedy Jr. Ackman is not denying his change. In fact, he said Kennedy…
[ad_1] It’s time to buy Glaukos ahead of some “exciting” product launches, Piper Sandler said. Analyst Matt O’Brien upgraded Glaukos to overweight, saying investors are overlooking the potential in its treatments for glaucoma, corneal disorders and retinal diseases, namely iDose and iStent. “While the name has run in recent weeks following iDose NDA submission, we…
[ad_1] Kenvue is well-positioned for accelerated growth following its separation from parent company Johnson & Johnson, according to JPMorgan. Following its spinoff earlier in May, Kenvue is the largest pure-play consumer health company in the world. The company holds commonly-known brands such as Neutrogena, Tylenol, Aveeno and Zyrtec — amounting to 10 brands with sales…
[ad_1] Last Updated: April 21, 2023, 06:25 IST Google parent Alphabet recently decided to cut roughly 12,000 jobs or 6 per cent workforce worldwide. The new division will be led by DeepMind CEO Demis Hassabis and its setting up will ensure ”bold and responsible development of general AI Alphabet Inc is combining Google Brain and…
